TesoRx is a virtual pharmaceutical company developing and commercializing pharmaceutical products. The company engages in developing and commercializing pharmaceutical products. It develops TSX-002, an oral therapeutic testosterone formulation for use in testosterone deficiency in men. The company was incorporated in 2010 and is based in Menlo Park, California.

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers. The company is developing a small molecule, oral chemotherapeutic, PCLX-001, to exploit this cancer mechanism by turning on selective lethality, apoptosis, in these cancer cells. The company's approach exploits a previously-unknown therapeutic target in cancer, making the drug a first-in-kind therapy. The diagnostic technology identifies those patients who will benefit from the drug, sparing many patients needless treatment. Pacylex Pharmaceuticals was founded on 2012 and is headquartered in Edmonton, Alberta, Canada.

The Academic Medical Center (Dutch: Academisch Medisch Centrum), or AMC, is the university hospital affiliated with the Universiteit van Amsterdam (University of Amsterdam). It is one of the largest and leading hospitals of The Netherlands, located in the Bijlmer neighborhood in the most south-eastern part of the city. AMC consistently ranks among the top 50 medical schools in the world.

BioMarck Pharmaceuticals, Ltd. is a privately owned biopharmaceutical company dedicated to the discovery and development of new drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of mucus and pulmonary inflammation. In developing its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma, and cystic fibrosis are later disease targets. BIO-11006 Inhalation Solution works by a novel dual mechanism; it inhibits both the secretion of mucus in the lungs and pulmonary inflammation. These aspects of BIO-11006 Inhalation Solution have been demonstrated in several different animal models. In addition, BioMarck has completed a full panel of preclinical safety studies, has an active IND with the FDA, has completed two BIO-11006 in Phase 1 clinical studies, and a Phase 2 study of the efficacy of BIO-11006 in COPD patients. Data from the Phase 2 study demonstrated proof-of-concept of BIO-11006. BioMarck licensed its technology on a worldwide exclusive basis from North Carolina State University, based on the work of Kenneth B. Adler, Ph.D., Professor of Cell Biology, and his co-workers.

Purac Biochem BV (doing business as Purac), part of Corbion NV, is a company headquartered in Gorinchem, the Netherlands. The firm develops and manufactures food preservatives, biobased chemicals and biopplastics.

Enzo Life Sciences, Inc. develops, produces and markets proprietary labeling and detection products for gene sequencing and genetic analysis. The firm provides DNA, RNA and protein quantification assays, genomics and general molecular biology tools, molecular labels and probes and compound libraries. The company is headquartered in Farmingdale, NY.

Mandom Corp. engages in the manufacture and sale of cosmetics, fragrance products and quasi-drugs. Its operations are carried out through the following business divisions: Cosmetics and Others. The Cosmetics division provides make-up kits, skin care, body care, hair care, hair colouring, daily grooming, and hair styling products for men and women. The Others division includes insurance agency business and building management services. The company was founded on December 23, 1927 and is headquartered in Osaka, Japan.

Servier Laboratories (doing business as Les Laboratories Servier) is a French private company located in Paris. The firm operates as a pharmaceutical company.\nThe company says this about itself: Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2020, Servier employs 22,500 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient's voice at the heart of its activities. A leader in cardiology, the ambition of the Servier Group is to become a recognized and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology and immuno-inflammatory, and neurodegenerative diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies.

Katakura & Co-Op Agri Corp. engages in the manufacture of fertilizers and fodders. It operates through the following segments: Fertilizers, Chemicals, Real Estate, and Others. The Fertilizers segment provides mixed fertilizers, chemical fertilizers, and paste fertilizers. It also produces propagation medium. The Chemicals segment manages the production of cosmetics, calcium phosphate for feed, industrial phosphoric acid, and synthetic mica. The Others segment includes overseas businesses, food, agricultural products, supplies, and other businesses such as plant design and construction, and transportation operations. The company was founded on March 14, 1920 and is headquartered in Tokyo, Japan.

Quanhou (Guangzhou) Biotechnology Research Institute Co., Ltd., established on 2019-01-18, Business scope includes biotechnology development services;Biotechnology Transfer Services;Biotechnology Consulting,communication service;Research and development of biological products(Does not include licensed operations);Medical Research and Experimental Development;Sales of plant extract raw materials(Does not include licensed operations,Projects prohibited by laws and regulations shall not be operated);Food Science and Technology Research Services;software development;computer technology development,Technical Services;Technical Services(Does not include license approval items);Health Sciences Program Research,to develop;Natural science research and experimental development;Information Technology Consulting Services;Operation of non-licensed medical devices;Packaging Technology Services;Technology Import and Export;electronic,Communication and Automatic Control Technology Research,to develop;Sales of packaging materials;Research and development of formula food for special medical purpose;Retailing of cosmetics and hygiene products;Wholesale of cosmetics and hygiene products;Wholesale of electronic products;Electronics retail;Instrument wholesale;

Guangdong Runhe New Material Technology Co., Ltd., established on 2007-04-30, The scope of business includes aircraft cabin seats,aircraft trailer,luggage trailer,baggage transfer vehicle,air-conditioned car,power car,Air source vehicle,cabin armrest,dining table,Design of cabin floor bead,Production(Without degreasing,pickling,spray paint),Sales,repair,Testing and Technical Consulting;Research,Development and manufacture of aerospace chemicals,Fine Chemicals(Free of Precursor Chemicals),Chemical Products(Excluding hazardous chemicals);Professional cleaning and disinfection of aircraft;Chemical and environmental protection equipment system,Research and development of mechatronic equipment systems,Sales and installation,manufacture(Restrict branches to operate in the park);Technical Advisory Services;Instrumentation and equipment,Aviation equipment,Manufacture of Civil Aircraft Decoration Parts,Sales;Production and sales of disinfection products;Online Trade Agent;export of goods or technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhejiang Paipide Biological Co., Ltd. Shenzhen Branch, established on 2021-08-16, Business scope includes general business items:Cosmetics Retail;Biochemical product technology research and development;Technical Services,technology development,technology transfer.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:none

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

The Boots Co. Plc owns and operates a chain of pharmaceutical and personal care retail stores. The firm’s stores are consists of local pharmacies, a healthcare-focused community stores; convenience and high-street stores offering pharmacy-led care. The company is headquartered in Nottingham, the United Kingdom.

Young Therapeutics supports I/R in the settings of heart attack and organ transplantation. They treat ischemia or reperfusion injury. They assist tissue down stream that is cut off from oxygen-carrying blood resulting in ischemic damage.

Guangzhou Nordrich Cosmetics Co., Ltd., established on 2010-04-20, Business scope includes import and export of goods(Excluding franchised products);Cosmetic Manufacturing;Business Management Consulting Services;Wholesale of cosmetics and hygiene products;Technology Import and Export;Soap and synthetic detergent manufacturing;Retailing of cosmetics and hygiene products;Operation of non-licensed medical devices;the medical,Medical Consulting Services(Does not involve a medical diagnosis,Treatment and Rehabilitation Services);Biomedical Technology Research;Medical technology research and development;Medical technology promotion service;Medical Technology Consulting,communication service;Medical supplies and equipment retail(Does not contain drugs and medical devices);

VastCon Inc. is a biotech company developing early screening and diagnostics for cancer. VastCon was founded in 2011 by Drs. Anuraag Shrivastav and Shailly Varma Shrivastav and is headquartered in Winnipeg, Manitoba, Canada. The company includes a team of basic research scientists with the mandate to take research from the laboratory to bedside. VastCon’s lead product is a novel blood test for the early detection and screening of colorectal cancer. Colorectal cancer is the second or third leading cause of death due to cancer world-wide, despite being one of the most curable cancers if detected early. Unfortunately for many people, by the time it is detected it is already at an advanced stage leading to death.

Linuo Biomedical Technology (Shanghai) Co., Ltd., established on 2019-06-11, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Cosmetics Retail;Chemical product sales(No licensed chemical products);Instrument sales;Sales of packaging materials and products;Experimental analysis instrument sales;Information Consulting Service(Not including licensing information consulting services);Conference and Exhibition Services;Import and export;Technology Import and Export;Manufacturing of daily chemical products;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Cosmetic production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Kao Corp. engages in the manufacture and sale of consumer and chemical products. It operates through the following segments: Consumer Products, Chemical, and Others. The Consumer Products segment includes Cosmetics, Skin Care and Hair Care, Human Health Care, Fabric and Home Care Businesses. The Cosmetics business offers make-up products such as RMK, SUQQU, Primavista, COFFRET DOR, KATE, SENSAI, and Molton Brown. The Skin Care and Hair Care business delivers skin care products such as facial cleansers, body cleansers, sunscreens, and body lotions. It also includes hair care products such as shampoos, conditioners, and hair colors. The Human Health Care business provides sanitary products such as Laurier sanitary napkins, Merries baby diapers, Relief adult diapers, Healthya functional beverage, Clear Clean, and Deep Clean toothpastes. The Fabric and Home Care business includes Attack and Newbeads laundry detergent, Humming and Flair Fragrance fabric softener, CuCute dishwashing detergent, and Magiclean household cleaners. The Chemical segment offers oleochemicals made from natural fat and oil, performance chemicals such as surfactants, and specialty chemicals such as toners and toner binders. The Others segment handles expansion and maintenance of logistics facilities and information technology (IT)-related investments. The company was founded by Tomiro Nagase on June 19, 1887 and is headquartered in Tokyo, Japan.